Quince Therapeutics
QNCX
QNCX
130 hedge funds and large institutions have $1.76B invested in Quince Therapeutics in 2021 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 48 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more funds holding
Funds holding: 105 → 130 (+25)
23% more call options, than puts
Call options by funds: $133M | Put options by funds: $108M
1.96% more ownership
Funds ownership: 62.67% → 64.64% (+2%)
Holders
130
Holding in Top 10
2
Calls
$133M
Puts
$108M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$17.2M | |
| 3 | +$14.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.85M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.63M |
Top Sellers
| 1 | -$29.7M | |
| 2 | -$11.2M | |
| 3 | -$3.19M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$3.05M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.51M |